Halloween has come and gone in the US, and Americans are now gearing up for Thanksgiving and Christmas. But before the holiday season could get underway, the country went through a major political event with far-reaching implications: the midterm elections.As…
HOME > BUSINESS
BUSINESS
- Xolair SC Pen Versions Go on Sale in Japan: Novartis
August 23, 2024
- Leqembi Approved in UK: Eisai
August 23, 2024
- Bayer Japan Says No Job Cuts to Soothe Employees’ Nerves as Xarelto Generics Loom
August 23, 2024
- Lilly’s BTK Inhibitor Jaypirca Hits Japan Market for MCL
August 22, 2024
- A Time for Patience - 1: New Drugs for ALS Emerging, Some Close to Approval; Can They Meet Unmet Needs?
August 22, 2024
- Rakuten Medical Japan VP Kodama Promoted to President
August 22, 2024
- Keytruda Regains Top-Selling Status in Japan in April-June: IQVIA
August 21, 2024
- Padcev Approved for Bladder Cancer in China: Astellas
August 21, 2024
- GSK’s Consumer Unit in Japan to Rebrand as Haleon in September
August 20, 2024
- Bayer Set to Finally List Xarelto AG in December, Espha as Distributor
August 20, 2024
- Enhertu Bags Breakthrough Therapy Tag for HER2 Low or Ultralow Breast Cancer
August 20, 2024
- Enhertu Grabs Conditional Nod for Gastric Cancer in China: Daiichi Sankyo
August 20, 2024
- Cheplapharm Snags 2 More Brands from Clinigen in Japan
August 20, 2024
- Otsuka Rolls Out Therapeutic App for Depression in US
August 19, 2024
- Fabhalta, Omjjara, Avigan Now Available in Japan
August 19, 2024
- Takeda Gets Japan Approval for Low-Dose Form of Ninlaro
August 19, 2024
- Insud/ASKA’s Birth Control Pill Approved in South Korea
August 19, 2024
- Breyanzi Broadens Label for Follicular Lymphoma in Japan: BMS
August 19, 2024
- Chugai Files DMD Gene Therapy Elevidys in Japan
August 19, 2024
- Rinvoq Filed for Giant Cell Arteritis in Japan: AbbVie
August 19, 2024
